Pay in 4 interest-free payments of $6.79 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
Naylor et al., 1998
Gastrointestinal side effects at this dose are generally well tolerated by individuals who progressed gradually through lower doses
The available studies differ in drug type, dose, indication, timing of exposure, comparator structure, and baseline maternal metabolic risk, and the number of exposed pregnancies remains insufficient to exclude uncommon but clinically important harms (132, 133)
Identification of a bioactive domain in the amino-terminus of glucose-dependent insulinotropic polypeptide (GIP)
doi:10.1007/8904_2016_531
The gastrointestinal microbiota in the development of ME/CFS: a critical view and potential perspectives
US$ 29.44
US$ 27.31
US$ 29.68
US$ 23.01
US$ 21.04
US$ 24.60
US$ 22.26
